Influence of immunosuppressive therapy on longitudinal changes in anti-SARS-CoV-2 spike protein antibodies after two doses of mRNA vaccines in patients with rheumatic diseases-Reference-Cited by-同舟云学术

Influence of immunosuppressive therapy on longitudinal changes in anti-SARS-CoV-2 spike protein antibodies after two doses of mRNA vaccines in patients with rheumatic diseases

Published:2023-07 Issue: Volume:113 Page:111-113
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Kawazoe Mai^ORCID,Aoki Kotaro^ORCID,Hirose Wataru,Masuoka Shotaro,Nanki Toshihiro^ORCID

Publisher

Elsevier BV

Subject

Internal Medicine

Reference10 articles.

1. American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: version 2;Curtis;Arthritis Rheumatol,2021

2. EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update;Landewé;Ann Rheum Dis,2022

3. Influence of vaccination and immunosuppressive treatments on the coronavirus disease 2019 outcomes in patients with systemic autoimmune diseases;Álvarez-Troncoso;Eur J Intern Med,2023

4. Humoral SARS-COV-2 IgG decay within 6 months in COVID-19 healthy vaccinees: the need for a booster vaccine dose?;Achiron;Eur J Intern Med,2021

5. BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus;Moyon;Ann Rheum Dis,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases;European Journal of Internal Medicine;2023-09